Leukemia Therapeutics Market - Global Industry Analysis

Leukemia Therapeutics Market

Leukemia Therapeutics Market Size, Growth Driver, Global Demand 2030

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1272 Published Date: Sep-2021 Status : Published

The global Leukemia Therapeutics Market size accounted for USD 13.85 Billion in 2020 and is expected to reach USD 24.70 Billion by 2028, growing at a CAGR of 7.5% from 2021 to 2028.

Table Of Content

Methodology

Free Analysis

Leukemia is cancer of the blood cells. Blood cells are red blood cells (RBC or erythrocyte), white blood cells (WBC or leukocyte) and platelets (thrombocytes). Most blood cells are generated in the bone marrow from hematopoietic stem cells (HSCs) and undergo maturation process called hematopoiesis. Hematopoietic stem cells give rise to both myeloid and lymphoid lineage cells and are capable of forming all three types of blood cells. In leukemia, immature blood cells undergo abnormal growth, forming a high number of cancerous cells called blasts. White blood cells are the most common type of blood cell to become cancer. Leukemia can be acute or chronic. Fast-growing cancer which worsens quickly as acute whereas slower-growing cancer that worsens slowly over time is chronic. Mainly there are four types of leukemia as chronic lymphatic leukemia, chronic myeloid leukemia, acute lymphatic leukemia and acute myeloid leukemia.

As per World Cancer Research Fund International, 352 cases of leukemia were diagnosed per 1000 people, in 2012.  As per National Cancer Institute, the numbers of expected new cases of leukemia in the US for 2016 are about 60,000 and about 24,000 estimated deaths. Approximately 1.5 percent of men and women will be diagnosed with leukemia at some point during their lifetime, based on 2011-2013 data. An estimated 1,185,053 people in the US are either living with or are in remission from, leukemia, lymphoma or myeloma. Treatment for leukemia depends on the type of blood cell affected and whether the leukemia is acute or chronic.

Novel drug discovery approaches and the need for early diagnosis along with growing incidence rate of target disease are expected to be the major drivers for the global leukemia therapeutics market. In addition, rising aging population base will surge the drug market worldwide in the coming years. However, the high price of a treatment therapy and lack of early detection techniques and awareness may pose the challenge to leukemia therapeutics market. Government funding and increasing healthcare expenditure across the globe are expected to act an opportunity for leukemia therapeutics market in near future.

Based on the type, leukemia therapeutics market has been segmented into acute leukemia, chronic leukemia, and others. Acute leukemia segment is subdivided into acute lymphatic leukemia and acute myeloid leukemia whereas chronic leukemia is sub-segmented as chronic lymphatic leukemia and chronic myeloid leukemia. The market is segmented into chemotherapy, biological therapy, radiation therapy, targeted therapy and other based on therapy. Based on geography, leukemia therapeutic market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.

North America is expected to remain the dominant region over the forecast period. High prevalence of target disease in this region and increasing healthcare awareness is expected to boost the market in this region. Europe was the second largest market followed by Asia-Pacific. Asia-Pacific is expected to show fastest growth rate during the forecast period. The Middle East and Africa, and Latin America are also expected to experience noticeable growth in the years to come.

Some of the key players in leukemia therapeutics market include F. Hoffmann-La Roche Ltd., Amgen, Bristol-Myers Squibb, Novartis International AG., Pfizer, Teva Pharmaceuticals, GlaxoSmithKline plc., Genzyme Corporation,  AbbVie Inc. and ARIAD Pharmaceuticals, Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed